Vacunas COVID-19 y esclerosis múltiple

[et_pb_section fb_built=»1″ fullwidth=»on» _builder_version=»4.17.6″ _module_preset=»default» background_image=»https://neuroexeltis.mx/wp-content/uploads/2022/05/AdobeStock_483897781-scaled.jpeg» parallax=»on» parallax_method=»off» transform_scale=»152%|140%» transform_scale_linked=»off» custom_margin=»24px||||false|false» global_colors_info=»{}» theme_builder_area=»post_content»][et_pb_fullwidth_header title=»Vacunas COVID-19 y esclerosis múltiple.» _builder_version=»4.17.6″ _module_preset=»default» title_font=»|700|||||||» title_text_align=»center» title_font_size=»27px» title_line_height=»1.6em» background_enable_color=»off» background_enable_image=»off» parallax=»on» parallax_method=»on» title_text_shadow_style=»preset4″ global_colors_info=»{}» theme_builder_area=»post_content»][/et_pb_fullwidth_header][/et_pb_section][et_pb_section fb_built=»1″ _builder_version=»4.17.4″ _module_preset=»default» custom_margin=»66px||||false|false» global_colors_info=»{}»][et_pb_row _builder_version=»4.17.6″ _module_preset=»default» hover_enabled=»0″ global_colors_info=»{}» custom_margin=»0px|auto||auto|false|false» use_custom_gutter=»on» make_equal=»on» sticky_enabled=»0″][et_pb_column type=»4_4″ _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]

Puesta al día sobre las vacunas disponibles para COVID-19 y la esclerosis múltiple por parte de expertos de Cemcat-Hospital Vall d’Hebron y Fundación Esclerosis Múltiple. 

[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=»1″ _builder_version=»4.17.4″ _module_preset=»default» custom_margin=»-24px||||false|false» global_colors_info=»{}»][et_pb_row _builder_version=»4.17.6″ _module_preset=»default» hover_enabled=»0″ global_colors_info=»{}» custom_margin=»0px||||false|false» sticky_enabled=»0″][et_pb_column type=»4_4″ _builder_version=»4.17.3″ _module_preset=»default» global_colors_info=»{}»][et_pb_code _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][/et_pb_code][et_pb_button button_url=»@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjIwOTcifX0=@» button_text=»Regresar» _builder_version=»4.17.4″ _dynamic_attributes=»button_url» _module_preset=»default» custom_button=»on» button_border_radius=»18px» global_colors_info=»{}»][/et_pb_button][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]

Vídeo avalado por: Centre d’Esclerosi Múltiple de Catalunya (Cemcat)

[/et_pb_text][et_pb_divider _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][/et_pb_divider][et_pb_image src=»https://neuroexeltis.mx/wp-content/uploads/2022/07/Logotipo-NeuroExeltis-Final_.png» title_text=»Logotipo NeuroExeltis-Final_» _builder_version=»4.17.6″ _module_preset=»default» custom_margin=»0px||||false|false» hover_enabled=»0″ global_colors_info=»{}» sticky_enabled=»0″][/et_pb_image][/et_pb_column][/et_pb_row][/et_pb_section]